Premium
EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells
Author(s) -
Hu HsienMing,
ZielinskaKwiatkowska Anna,
Munro Karen,
Wilcox Jason,
Wu Daniel Y.,
Yang Liu,
Chansky Howard A.
Publication year - 2008
Publication title -
journal of orthopaedic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.041
H-Index - 155
eISSN - 1554-527X
pISSN - 0736-0266
DOI - 10.1002/jor.20597
Subject(s) - cyclin d1 , fli1 , gene knockdown , retinoblastoma protein , retinoblastoma , senescence , cancer research , fusion protein , ewing's sarcoma , biology , phenotype , cyclin , microbiology and biotechnology , cell cycle , gene , transcription factor , genetics , recombinant dna , chemotherapy
Ewing's Family Tumors (EFTs) most commonly harbor a specific t(11;22) translocation that generates the EWS/FLI1 fusion protein responsible for malignant transformation. Many potential downstream targets of EWS/FLI1 have been identified but a detailed mechanism by which the fusion protein brings about transformation remains unknown. In this report, we show that depletion of EWS/FLI1 in Ewing's cell lines results in a senescence phenotype, a marked increase in expression of the G1/S regulatory proteins p27 kip1 and p57 kip2 , and a significant decrease in cyclin D1 and CDK2. We also demonstrate for the first time, to our knowledge, that knockdown of EWS/FLI1 leads to hypophosphorylation and functional activation of the retinoblastoma (pRb) family of proteins. Consistent with activation of the pRb proteins, E2F‐responsive genes such as cyclin A are repressed in EWS/FLI1‐depleted cells. Together, these results support the role of EWS/LI1 as an inhibitor of cellular senescence and implicate the retinoblastoma family of proteins as key mediators of this inhibition. © 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 26:886–893, 2008